[
  {
    "ts": null,
    "headline": "Merck & Co. Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
    "summary": "Merck & Co. Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=e1966ce2fcddfb9dc34c5ad273dc31473d8bf1bdf2d3d58c87a9fa602bd0cb37",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736267700,
      "headline": "Merck & Co. Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
      "id": 132322276,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Merck & Co. Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=e1966ce2fcddfb9dc34c5ad273dc31473d8bf1bdf2d3d58c87a9fa602bd0cb37"
    }
  },
  {
    "ts": null,
    "headline": "Top 5 Commercial Biotech Buyout Candidates: Day One Biopharmaceuticals (No. 5)",
    "summary": "Day One Biopharmaceuticals focuses on pediatric cancer treatments. Read more about the biotech's therapies and its prospects for 2025.",
    "url": "https://finnhub.io/api/news?id=f1588fec1459d5307c6fb14d2a4090f5abed15b46fc8ab0d4ba8d1e2024cdad0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736249479,
      "headline": "Top 5 Commercial Biotech Buyout Candidates: Day One Biopharmaceuticals (No. 5)",
      "id": 132302431,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1403479106/image_1403479106.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Day One Biopharmaceuticals focuses on pediatric cancer treatments. Read more about the biotech's therapies and its prospects for 2025.",
      "url": "https://finnhub.io/api/news?id=f1588fec1459d5307c6fb14d2a4090f5abed15b46fc8ab0d4ba8d1e2024cdad0"
    }
  },
  {
    "ts": null,
    "headline": "IBM, Walt Disney share gains lead Dow's 167-point jump",
    "summary": "IBM, Walt Disney share gains lead Dow's 167-point jump",
    "url": "https://finnhub.io/api/news?id=2b7009e169f366f250f47514587e15f505704996f14a5f223e112feb562fc6bd",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736243100,
      "headline": "IBM, Walt Disney share gains lead Dow's 167-point jump",
      "id": 132322277,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "IBM, Walt Disney share gains lead Dow's 167-point jump",
      "url": "https://finnhub.io/api/news?id=2b7009e169f366f250f47514587e15f505704996f14a5f223e112feb562fc6bd"
    }
  },
  {
    "ts": null,
    "headline": "WuXi Biologics to Sell Irish Vaccine Facility to Merck for $500 Million",
    "summary": "WuXi Biologics’ move to sell the facility could strengthen the company’s cash flow and margins as it navigates global uncertainties.",
    "url": "https://finnhub.io/api/news?id=6ff9ecddfa975dd8f9d755d24ebc536fda3c8d912f40d15bf2145ac24d613cea",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736231760,
      "headline": "WuXi Biologics to Sell Irish Vaccine Facility to Merck for $500 Million",
      "id": 132297937,
      "image": "",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "WuXi Biologics’ move to sell the facility could strengthen the company’s cash flow and margins as it navigates global uncertainties.",
      "url": "https://finnhub.io/api/news?id=6ff9ecddfa975dd8f9d755d24ebc536fda3c8d912f40d15bf2145ac24d613cea"
    }
  }
]